FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2158175963> ?p ?o ?g. }

• W2158175963 endingPage "144" @default.
• W2158175963 startingPage "144" @default.
• W2158175963 abstract "Tendon disorders comprise 30% to 50% of all activity-related injuries; chronic degenerative tendon disorders (tendinopathy) occur frequently and are difficult to treat. Tendon regeneration might be improved by injecting platelet-rich plasma (PRP), an increasingly used treatment for releasing growth factors into the degenerative tendon.To examine whether a PRP injection would improve outcome in chronic midportion Achilles tendinopathy.A stratified, block-randomized, double-blind, placebo-controlled trial at a single center (The Hague Medical Center, Leidschendam, The Netherlands) of 54 randomized patients aged 18 to 70 years with chronic tendinopathy 2 to 7 cm above the Achilles tendon insertion. The trial was conducted between August 28, 2008, and January 29, 2009, with follow-up until July 16, 2009.Eccentric exercises (usual care) with either a PRP injection (PRP group) or saline injection (placebo group). Randomization was stratified by activity level.The validated Victorian Institute of Sports Assessment-Achilles (VISA-A) questionnaire, which evaluated pain score and activity level, was completed at baseline and 6, 12, and 24 weeks. The VISA-A score ranged from 0 to 100, with higher scores corresponding with less pain and increased activity. Treatment group effects were evaluated using general linear models on the basis of intention-to-treat.After randomization into the PRP group (n = 27) or placebo group (n = 27), there was complete follow-up of all patients. The mean VISA-A score improved significantly after 24 weeks in the PRP group by 21.7 points (95% confidence interval [CI], 13.0-30.5) and in the placebo group by 20.5 points (95% CI, 11.6-29.4). The increase was not significantly different between both groups (adjusted between-group difference from baseline to 24 weeks, -0.9; 95% CI, -12.4 to 10.6). This CI did not include the predefined relevant difference of 12 points in favor of PRP treatment.Among patients with chronic Achilles tendinopathy who were treated with eccentric exercises, a PRP injection compared with a saline injection did not result in greater improvement in pain and activity.clinicaltrials.gov Identifier: NCT00761423." @default.
• W2158175963 created "2016-06-24" @default.
• W2158175963 creator A5000696380 @default.
• W2158175963 creator A5009190550 @default.
• W2158175963 creator A5010589860 @default.
• W2158175963 creator A5013980875 @default.
• W2158175963 creator A5035697100 @default.
• W2158175963 creator A5038360599 @default.
• W2158175963 creator A5077676327 @default.
• W2158175963 date "2010-01-13" @default.
• W2158175963 modified "2023-10-16" @default.
• W2158175963 title "Platelet-Rich Plasma Injection for Chronic Achilles Tendinopathy" @default.
• W2158175963 cites W1980128180 @default.
• W2158175963 cites W1984002790 @default.
• W2158175963 cites W1994811861 @default.
• W2158175963 cites W1994855047 @default.
• W2158175963 cites W2015986868 @default.
• W2158175963 cites W2016774778 @default.
• W2158175963 cites W2026293290 @default.
• W2158175963 cites W2030012902 @default.
• W2158175963 cites W2030322516 @default.
• W2158175963 cites W2031280537 @default.
• W2158175963 cites W2041915062 @default.
• W2158175963 cites W2050144156 @default.
• W2158175963 cites W2057647525 @default.
• W2158175963 cites W2059470830 @default.
• W2158175963 cites W2069634327 @default.
• W2158175963 cites W2081602516 @default.
• W2158175963 cites W2088530651 @default.
• W2158175963 cites W2092864984 @default.
• W2158175963 cites W2096813909 @default.
• W2158175963 cites W2120835553 @default.
• W2158175963 cites W2121620043 @default.
• W2158175963 cites W2124525370 @default.
• W2158175963 cites W2131812889 @default.
• W2158175963 cites W2135956897 @default.
• W2158175963 cites W2136871488 @default.
• W2158175963 cites W2137270584 @default.
• W2158175963 cites W2138193631 @default.
• W2158175963 cites W2142354391 @default.
• W2158175963 cites W2143488080 @default.
• W2158175963 cites W2155579628 @default.
• W2158175963 cites W2161615595 @default.
• W2158175963 cites W2163241040 @default.
• W2158175963 cites W2187510678 @default.
• W2158175963 doi "https://doi.org/10.1001/jama.2009.1986" @default.
• W2158175963 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20068208" @default.
• W2158175963 hasPublicationYear "2010" @default.
• W2158175963 type Work @default.
• W2158175963 sameAs 2158175963 @default.
• W2158175963 citedByCount "751" @default.
• W2158175963 countsByYear W21581759632012 @default.
• W2158175963 countsByYear W21581759632013 @default.
• W2158175963 countsByYear W21581759632014 @default.
• W2158175963 countsByYear W21581759632015 @default.
• W2158175963 countsByYear W21581759632016 @default.
• W2158175963 countsByYear W21581759632017 @default.
• W2158175963 countsByYear W21581759632018 @default.
• W2158175963 countsByYear W21581759632019 @default.
• W2158175963 countsByYear W21581759632020 @default.
• W2158175963 countsByYear W21581759632021 @default.
• W2158175963 countsByYear W21581759632022 @default.
• W2158175963 countsByYear W21581759632023 @default.
• W2158175963 crossrefType "journal-article" @default.
• W2158175963 hasAuthorship W2158175963A5000696380 @default.
• W2158175963 hasAuthorship W2158175963A5009190550 @default.
• W2158175963 hasAuthorship W2158175963A5010589860 @default.
• W2158175963 hasAuthorship W2158175963A5013980875 @default.
• W2158175963 hasAuthorship W2158175963A5035697100 @default.
• W2158175963 hasAuthorship W2158175963A5038360599 @default.
• W2158175963 hasAuthorship W2158175963A5077676327 @default.
• W2158175963 hasConcept C126322002 @default.
• W2158175963 hasConcept C141071460 @default.
• W2158175963 hasConcept C142724271 @default.
• W2158175963 hasConcept C168563851 @default.
• W2158175963 hasConcept C1862650 @default.
• W2158175963 hasConcept C204243189 @default.
• W2158175963 hasConcept C204787440 @default.
• W2158175963 hasConcept C27081682 @default.
• W2158175963 hasConcept C2778911562 @default.
• W2158175963 hasConcept C2780076745 @default.
• W2158175963 hasConcept C2780105995 @default.
• W2158175963 hasConcept C2780984734 @default.
• W2158175963 hasConcept C71924100 @default.
• W2158175963 hasConcept C89560881 @default.
• W2158175963 hasConceptScore W2158175963C126322002 @default.
• W2158175963 hasConceptScore W2158175963C141071460 @default.
• W2158175963 hasConceptScore W2158175963C142724271 @default.
• W2158175963 hasConceptScore W2158175963C168563851 @default.
• W2158175963 hasConceptScore W2158175963C1862650 @default.
• W2158175963 hasConceptScore W2158175963C204243189 @default.
• W2158175963 hasConceptScore W2158175963C204787440 @default.
• W2158175963 hasConceptScore W2158175963C27081682 @default.
• W2158175963 hasConceptScore W2158175963C2778911562 @default.
• W2158175963 hasConceptScore W2158175963C2780076745 @default.
• W2158175963 hasConceptScore W2158175963C2780105995 @default.
• W2158175963 hasConceptScore W2158175963C2780984734 @default.
• W2158175963 hasConceptScore W2158175963C71924100 @default.

• next